scholarly journals Association Between High-Sensitive Measurement of C-Reactive Protein and Metabolic Syndrome as Defined by International Diabetes Federation, National Cholesterol Education Program, and World Health Organization Criteria in a Population-Based Cohort of 55-Year-Old Finnish Individuals

Diabetes Care ◽  
2006 ◽  
Vol 29 (9) ◽  
pp. 2177-2178 ◽  
Author(s):  
P. K. Hirsso ◽  
M. J. Timonen ◽  
J. J. Jokelainen ◽  
L. A. Hiltunen ◽  
M. A. Laakso ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
World Health Organization ◽  
Education Program ◽  
National Cholesterol Education Program ◽  
International Diabetes Federation ◽  
Population Based ◽  
World Health ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Health Organization

scholarly journals Metabolic syndrome and schizophrenia

2005 ◽  
Vol 186 (6) ◽  
pp. 455-456 ◽  
Author(s):  
Jogin H. Thakore
Keyword(s):  
Metabolic Syndrome ◽  
World Health Organization ◽  
Education Program ◽  
National Cholesterol Education Program ◽  
Reference Population ◽  
World Health ◽  
Adult Treatment Panel ◽  
The World ◽  
Health Organization

Metabolic syndrome – a cluster of disorders comprising obesity (central and abdominal), dyslipidaemias, glucose intolerance, insulin resistance (or hyperinsulinaemia) and hypertension – is highly predictive of type 2 diabetes mellitus and cardiovascular disease. In order to improve detection of this syndrome and estimate its prevalence, both the World Health Organization (Alberti & Zimmet, 1998) and the National Cholesterol Education Program Adult Treatment Panel (National Cholesterol Education Program, 2001) have provided working criteria for its diagnosis (the World Health Organization criteria are reproduced in an appendix to this paper; copyright restrictions prevent the inclusion here of the National Cholesterol Education Program criteria). Using the latter criteria, Heiskanen et al (2003) found that the frequency of metabolic syndrome was 2–4 times higher in a group of people with schizophrenia, treated with both atypical and typical neuroleptics, than in an appropriate reference population.

O DIAGNÓSTICO DA SÍNDROME METABÓLICA ANALISADO SOB DIFERENTES CRITÉRIOS DE DEFINIÇÃO

2015 ◽  
Vol 39 (3) ◽  
pp. 482
Author(s):  
Cati Reckelberg Azambuja ◽  
Juliano Boufleur Farinha ◽  
Daniela Sastre Rossi ◽  
Carla Francieli Spohr ◽  
Daniela Lopes dos Santos
Keyword(s):  
World Health Organization ◽  
Education Program ◽  
National Cholesterol Education Program ◽  
International Diabetes Federation ◽  
World Health ◽  
Sindrome Metabolica ◽  
Health Organization

A síndrome metabólica é uma doença crônica representada por um conjunto de fatores de riscos cardiovasculares. O objetivo deste estudo foi analisar o diagnóstico da síndrome metabólica sob diferentes critérios de definição. Foram avaliados parâmetros antropométricos, bioquímicos e hemodinâmicos de 125 indivíduos. A prevalência de síndrome metabólica variou conforme o critério utilizado para análise: 16,8% (World Health Organization), 57,6% (National Cholesterol Education Program) e 75,2% (International Diabetes Federation). A diferença na prevalência de síndrome metabólica apresentada para a mesma amostra nos leva a concluir que a obrigatoriedade da disfunção relacionada à glicose, apresentada pela Organização Mundial da Saúde, subestima muitos casos do diagnóstico por não considerar outros fatores de risco, como por exemplo a hipertensão, a dislipidemia e a obesidade central, que podem estar presentes no indivíduo.

Sign in / Sign up

Export Citation Format

Share Document